# Voyageur Pharmaceuticals Advances Mueller Iodine Extraction Process with 99.8% Purity Results and Planned Field Pilot Testing

Canonical Atlas analysis: https://atlas-extractions.minestarters.com/news/voyageur-pharmaceuticals-advances-mueller-iodine-extraction-process-with-99-8-pu--abc11f32-d774-464f-8a29-a4e47f67ce05

Original source: https://money.tmx.com/en/quote/VM/news/5100058791871775/voyageur-pharmaceuticals-advances-mueller-iodine-extraction-process-with-99-8-pu

Publisher: tmx

Original announcement: 2026-08-10T11:00:00.000Z

Analysis by Minestarters Atlas

Atlas analysis published: Unknown date

Atlas analysis updated: Unknown date

- Company: Voyageur Pharmaceuticals Ltd.

- Ticker: VM

- Exchange: TSX

- Region: Texas

- Primary commodity: Iodine

- Secondary commodities: Barium

- Document categories: Metallurgy, Other

- Extracted: 2026-09-13 06:23:27 UTC

Narrative sentiment: 0.60 · Bullish

## Minestarters Atlas summary

Voyageur Pharmaceuticals has reported successful laboratory results for its Mueller iodine extraction process, achieving 99.8% purity and over 90% recovery from oilfield brine. The company has constructed a mobile pilot unit and plans to commence field testing in September 2026.

Reasoning: Successful laboratory validation of high-purity iodine extraction from oilfield brine, moving toward field pilot testing.

- Positive factor: High purity results \(99.8%\)

- Positive factor: Strong recovery \(>90%\)

- Positive factor: Transition from lab to field pilot stage

- Positive factor: Modular production concept

- Negative factor: Field testing has not yet commenced

Facts used in scoring: 1

## Classification and evidence

**High Recovery**

Polarity: positive

Definition: Recovery at or above the exceptional band for the commodity and processing route.

Why it applies: Reported recovery exceeds 90% in laboratory testing.

Evidence · text

> overall process recovery exceeding 90%

**Bench Scale Only**

Polarity: negative

Definition: Only preliminary bench tests completed — no locked-cycle or pilot work.

Why it applies: Current results are from laboratory work; field pilot testing is only scheduled to begin in September 2026.

Evidence · text

> moving beyond bench-scale validation toward continuous, real-world field operation

**Mill Route**

Polarity: neutral

Definition: Processing via mill or concentrator \(CIL, CIP, tank leach, flotation\).

Why it applies: the document describes a flotation route \("concentrate"\)

**Single Domain Only**

Polarity: negative

Definition: Testing limited to one composite or domain — representativeness not established.

Why it applies: only one composite was tested

## Extracted facts

Stored fact records: 1. Some facts used in scoring do not have a stored record.

## Metallurgical Results (1)

### laboratory

[Link to this fact](https://atlas-extractions.minestarters.com/news/voyageur-pharmaceuticals-advances-mueller-iodine-extraction-process-with-99-8-pu--abc11f32-d774-464f-8a29-a4e47f67ce05#fact-metallurgical-facts-0)

Mueller process · iodine

#### Identity

- Project: Mueller process
- Commodity: iodine
- Region: texas
- Reported Region: Texas
- Ticker: VM

#### Test Work

- Program Status: preliminary
- Test Type: laboratory
- Processing Route: Mueller iodine extraction process
- Sample: laboratory work using real oilfield brine

#### Recovery

- Recovery: 90 %
- Conc. Grade: 99.8
- Conc. Grade Unit: % purity

#### Review

- Needs Review: No
- Historical: No

#### Dates

- Event date: 2026-08-10T00:00:00.000Z

Reasoning: Laboratory results demonstrate high technical viability for the extraction process.

- Positive factor: High purity

- Positive factor: High recovery

Evidence · text

> successfully produced iodine at 99.8% purity, with overall process recovery exceeding 90%

## How Atlas produces this analysis

Minestarters Atlas uses automated extraction to summarize mining announcements, identify reported measurements, and classify supporting evidence. Sentiment reflects the extracted narrative and classification rules; it is an interpretation, not a reported measurement. Evidence quotes and context are provided where available. Missing data, low-confidence results, and review flags indicate limitations. Check the original publisher announcement before relying on an interpretation.